1. Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
   Sara Elena Rebuzzi et al, 2023, Cancers CrossRef
2. A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era
   Anca-Narcisa Neagu et al, 2024, International Journal of Molecular Sciences CrossRef
3. Identification of an 11-miRNA-regulated and surface-protein genes signature predicts the prognosis of lung adenocarcinoma based on multi-omics study
   Kunyu Guo, 2024, American Journal of Translational Research CrossRef
4. Biological function, regulatory mechanism, and clinical application of mannose in cancer
   Haoyi Jin et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
5. Design strategies for enhancing antitumor efficacy through tumor microenvironment exploitation using albumin-based nanosystems: A review
   Cai Zhang et al, 2024, International Journal of Biological Macromolecules CrossRef
6. Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma
   Hualan Hong et al, 2024, Biomedical Reports CrossRef
7. Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
   Fabio Catalano et al, 2024, Future Oncology CrossRef
8. Overview of cancer: Mechanisms of carcinogenesis
   Uttara Saran et al, 2024, Cancer Epigenetics and Nanomedicine CrossRef
9. FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
   Xumeng Gong et al, 2023, Frontiers in Oncology CrossRef
10. OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer
    Zhong Yu et al, 2023, Discover Oncology CrossRef
11. Paving Way for a Paradigm Shift in Oncology: Curing Cancer by Loving It?
    Vuk Uskoković, 2023, Micro CrossRef